Oligogen Inc.
Toward a Future of Greatly Creating Humanity's Abundance
Close
menu
ja
en
HOME
Access
Site Use Policy
COMPANY
Message
Philosophy
History
Profile
NEWS
News
Press Release
R&D
IR
PROJECTS
Cell Therapy
Exosome Therapy
Drug Discovery
ACHIEVEMENTS
Awards
Funding
Grants
Collaboration/Partnership
Events
Media
Close
COMPANY
Go to COMPANY
Message
Philosophy
History
Profile
HOME
ACHIEVEMENTS
Funding
Funding（CY2016-CY2021）
ACHIEVEMENTS
Awards
Awards（CY2016-CY2021）
Collaboration/Partnership
Collaboration/Partnership（CY2016-CY2021）
Events
Events（CY2016-CY2021）
Events（CY2022-）
Funding
Funding（CY2016-CY2021）
Grants
Grants（CY2016-CY2021）
Media
Media（CY2016-CY2021）
Funding（CY2016-CY2021）
Fundraising
Raised funds through crowdfunding
Notice Concerning Issuance of New Shares by way of Third-Party Allotment (A-2 Series)
New shares were issued through a third-party allotment (Series A-1).
